AAV-mediated astrocyte-specific gene expression under human ALDH1L1 promoter in mouse thalamus

Wuhyun Koh, Yongmin Mason Park, Seung Eun Lee, Changjoon Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Adeno-associated virus (AAV)-mediated gene delivery has been proposed to be an essential tool of gene therapy for various brain diseases. Among several cell types in the brain, astrocyte has become a promising therapeutic target for brain diseases, as more and more contribution of astrocytes in pathophysiology has been revealed. Until now, genetically targeting astrocytes has been possible by utilizing the glial fibrillary acidic protein (GFAP) promoter. In some brain areas including thalamus, however, the GFAP expression in astrocytes is reported to be low, making it difficult to genetically target astrocytes using GFAP promoter. To study the function of astrocytes in thalamus, which serves as a relay station, there is a great need for identifying an alternative astrocyte-specific promoter in thalamus. Recently, a new astrocyte-specific promoter of ALDH1L1 has been identified. However, it has not been examined in thalamus. Here we developed and characterized an AAV vector expressing Cre recombinase under the human ALDH1L1 promoter, AAV-hALDH1L1-Cre. To test the cell-type specific expression of AAV-hALDH1L1-Cre, AAV virus was injected into several brain regions of Ai14 (RCL-tdTomato) mouse, which reports Cre activity by tdTomato expression. In thalamus, we observed that tdTomato was found mostly in astrocytes (91.71%), with minimal occurrence in neurons (2.67%). In contrast, tdTomato signal was observed in both neurons and astrocytes of the amygdala (neuron: 68.13%, astrocyte: 28.35%) and hippocampus (neuron: 76.25%, astrocyte: 18.00%), which is consistent with the previous report showing neuronal gene expression under rat ALDH1L1 promoter. Unexpectedly, tdTomato was found mostly in neurons (91.98%) with minimal occurrence in astrocytes (6.66%) of the medial prefrontal cortex. In conclusion, hALDH1L1 promoter shows astrocyte-specificity in thalamus and may prove to be useful for targeting thalamic astrocytes in mouse.

Original languageEnglish
Pages (from-to)350-361
Number of pages12
JournalExperimental Neurobiology
Volume26
Issue number6
DOIs
Publication statusPublished - 2017 Dec 1
Externally publishedYes

Fingerprint

Dependovirus
Thalamus
Astrocytes
Gene Expression
Glial Fibrillary Acidic Protein
Neurons
Brain Diseases
Brain
Essential Genes
Amygdala
Prefrontal Cortex
Genetic Therapy

Keywords

  • ALDH1L1 protein
  • Astrocytes
  • Cre recombinase
  • Dependovirus
  • Glial fibrillary acidic protein
  • Human
  • Ventral thalamic nuclei

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

AAV-mediated astrocyte-specific gene expression under human ALDH1L1 promoter in mouse thalamus. / Koh, Wuhyun; Park, Yongmin Mason; Lee, Seung Eun; Lee, Changjoon.

In: Experimental Neurobiology, Vol. 26, No. 6, 01.12.2017, p. 350-361.

Research output: Contribution to journalArticle

Koh, Wuhyun ; Park, Yongmin Mason ; Lee, Seung Eun ; Lee, Changjoon. / AAV-mediated astrocyte-specific gene expression under human ALDH1L1 promoter in mouse thalamus. In: Experimental Neurobiology. 2017 ; Vol. 26, No. 6. pp. 350-361.
@article{ff1161ac96ff4e25b1d49cbbe134fc1f,
title = "AAV-mediated astrocyte-specific gene expression under human ALDH1L1 promoter in mouse thalamus",
abstract = "Adeno-associated virus (AAV)-mediated gene delivery has been proposed to be an essential tool of gene therapy for various brain diseases. Among several cell types in the brain, astrocyte has become a promising therapeutic target for brain diseases, as more and more contribution of astrocytes in pathophysiology has been revealed. Until now, genetically targeting astrocytes has been possible by utilizing the glial fibrillary acidic protein (GFAP) promoter. In some brain areas including thalamus, however, the GFAP expression in astrocytes is reported to be low, making it difficult to genetically target astrocytes using GFAP promoter. To study the function of astrocytes in thalamus, which serves as a relay station, there is a great need for identifying an alternative astrocyte-specific promoter in thalamus. Recently, a new astrocyte-specific promoter of ALDH1L1 has been identified. However, it has not been examined in thalamus. Here we developed and characterized an AAV vector expressing Cre recombinase under the human ALDH1L1 promoter, AAV-hALDH1L1-Cre. To test the cell-type specific expression of AAV-hALDH1L1-Cre, AAV virus was injected into several brain regions of Ai14 (RCL-tdTomato) mouse, which reports Cre activity by tdTomato expression. In thalamus, we observed that tdTomato was found mostly in astrocytes (91.71{\%}), with minimal occurrence in neurons (2.67{\%}). In contrast, tdTomato signal was observed in both neurons and astrocytes of the amygdala (neuron: 68.13{\%}, astrocyte: 28.35{\%}) and hippocampus (neuron: 76.25{\%}, astrocyte: 18.00{\%}), which is consistent with the previous report showing neuronal gene expression under rat ALDH1L1 promoter. Unexpectedly, tdTomato was found mostly in neurons (91.98{\%}) with minimal occurrence in astrocytes (6.66{\%}) of the medial prefrontal cortex. In conclusion, hALDH1L1 promoter shows astrocyte-specificity in thalamus and may prove to be useful for targeting thalamic astrocytes in mouse.",
keywords = "ALDH1L1 protein, Astrocytes, Cre recombinase, Dependovirus, Glial fibrillary acidic protein, Human, Ventral thalamic nuclei",
author = "Wuhyun Koh and Park, {Yongmin Mason} and Lee, {Seung Eun} and Changjoon Lee",
year = "2017",
month = "12",
day = "1",
doi = "10.5607/en.2017.26.6.350",
language = "English",
volume = "26",
pages = "350--361",
journal = "Experimental Neurobiology",
issn = "1226-2560",
publisher = "Korean Society for Brain and Neural Science",
number = "6",

}

TY - JOUR

T1 - AAV-mediated astrocyte-specific gene expression under human ALDH1L1 promoter in mouse thalamus

AU - Koh, Wuhyun

AU - Park, Yongmin Mason

AU - Lee, Seung Eun

AU - Lee, Changjoon

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Adeno-associated virus (AAV)-mediated gene delivery has been proposed to be an essential tool of gene therapy for various brain diseases. Among several cell types in the brain, astrocyte has become a promising therapeutic target for brain diseases, as more and more contribution of astrocytes in pathophysiology has been revealed. Until now, genetically targeting astrocytes has been possible by utilizing the glial fibrillary acidic protein (GFAP) promoter. In some brain areas including thalamus, however, the GFAP expression in astrocytes is reported to be low, making it difficult to genetically target astrocytes using GFAP promoter. To study the function of astrocytes in thalamus, which serves as a relay station, there is a great need for identifying an alternative astrocyte-specific promoter in thalamus. Recently, a new astrocyte-specific promoter of ALDH1L1 has been identified. However, it has not been examined in thalamus. Here we developed and characterized an AAV vector expressing Cre recombinase under the human ALDH1L1 promoter, AAV-hALDH1L1-Cre. To test the cell-type specific expression of AAV-hALDH1L1-Cre, AAV virus was injected into several brain regions of Ai14 (RCL-tdTomato) mouse, which reports Cre activity by tdTomato expression. In thalamus, we observed that tdTomato was found mostly in astrocytes (91.71%), with minimal occurrence in neurons (2.67%). In contrast, tdTomato signal was observed in both neurons and astrocytes of the amygdala (neuron: 68.13%, astrocyte: 28.35%) and hippocampus (neuron: 76.25%, astrocyte: 18.00%), which is consistent with the previous report showing neuronal gene expression under rat ALDH1L1 promoter. Unexpectedly, tdTomato was found mostly in neurons (91.98%) with minimal occurrence in astrocytes (6.66%) of the medial prefrontal cortex. In conclusion, hALDH1L1 promoter shows astrocyte-specificity in thalamus and may prove to be useful for targeting thalamic astrocytes in mouse.

AB - Adeno-associated virus (AAV)-mediated gene delivery has been proposed to be an essential tool of gene therapy for various brain diseases. Among several cell types in the brain, astrocyte has become a promising therapeutic target for brain diseases, as more and more contribution of astrocytes in pathophysiology has been revealed. Until now, genetically targeting astrocytes has been possible by utilizing the glial fibrillary acidic protein (GFAP) promoter. In some brain areas including thalamus, however, the GFAP expression in astrocytes is reported to be low, making it difficult to genetically target astrocytes using GFAP promoter. To study the function of astrocytes in thalamus, which serves as a relay station, there is a great need for identifying an alternative astrocyte-specific promoter in thalamus. Recently, a new astrocyte-specific promoter of ALDH1L1 has been identified. However, it has not been examined in thalamus. Here we developed and characterized an AAV vector expressing Cre recombinase under the human ALDH1L1 promoter, AAV-hALDH1L1-Cre. To test the cell-type specific expression of AAV-hALDH1L1-Cre, AAV virus was injected into several brain regions of Ai14 (RCL-tdTomato) mouse, which reports Cre activity by tdTomato expression. In thalamus, we observed that tdTomato was found mostly in astrocytes (91.71%), with minimal occurrence in neurons (2.67%). In contrast, tdTomato signal was observed in both neurons and astrocytes of the amygdala (neuron: 68.13%, astrocyte: 28.35%) and hippocampus (neuron: 76.25%, astrocyte: 18.00%), which is consistent with the previous report showing neuronal gene expression under rat ALDH1L1 promoter. Unexpectedly, tdTomato was found mostly in neurons (91.98%) with minimal occurrence in astrocytes (6.66%) of the medial prefrontal cortex. In conclusion, hALDH1L1 promoter shows astrocyte-specificity in thalamus and may prove to be useful for targeting thalamic astrocytes in mouse.

KW - ALDH1L1 protein

KW - Astrocytes

KW - Cre recombinase

KW - Dependovirus

KW - Glial fibrillary acidic protein

KW - Human

KW - Ventral thalamic nuclei

UR - http://www.scopus.com/inward/record.url?scp=85039162564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039162564&partnerID=8YFLogxK

U2 - 10.5607/en.2017.26.6.350

DO - 10.5607/en.2017.26.6.350

M3 - Article

VL - 26

SP - 350

EP - 361

JO - Experimental Neurobiology

JF - Experimental Neurobiology

SN - 1226-2560

IS - 6

ER -